V-Raf murine sarcoma viral oncogene homolog B1 (BRAF) encodes a serine-threonine
kinase. The V600E point mutation in the BRAF gene is the most common mutation …

Background Ameloblastoma is an aggressively growing, highly recurrent odontogenic jaw
tumor. Its association with BRAFV600E mutation is an indication for BRAFV00E‐inhibitor …

Emerging studies show that long intergenic non-protein coding RNA, regulator of
reprogramming (LINC-ROR) is aberrantly expressed in several types of cancer, including …

Background An aberrant expression of long non‐coding RNA PVT1 has been associated
with apoptosis in various cancer types. We aimed to explore the PVT1 and four apoptosis …

Objective: Colon cancer (CC) remains one of the leading causes of cancer death worldwide.
Several mutations/polymorphisms have been implicated in CC development and/or …

Differentiated thyroid tumors (DTC) are the most common indolent tumors associated with a
good prognosis compared with other tumors. Its incidence during the last few decades has …

A myriad of histological variants of papillary thyroid carcinoma (PTC) have been described,
some of which can be diagnostically challenging due to their rarity and overlap** …

Immunohistochemistry (IHC) is an economic and precise method to localize the presence of
specific protein at cellular level in tissue. Although many papillary thyroid carcinomas do not …

Abstract Background and Objectives: In papillary thyroid cancer (PTC), BRAF V600E is the
most prevalent genetic alteration, and in different populations, its frequency ranges from …

Background: BRAF V600E mutation, with incidence rates ranging from 29% to 83% of
papillary thyroid carcinoma (PTC), is the most common genetic mutation. Several methods …